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Abstract 
We investigated the subcellular distribution of dopamine D1, D2 and D5 receptor subtypes in rat 
frontal cortex, and examined whether psychostimulant-induced elevation of synaptic dopamine 
could alter the receptor distribution. Differential detergent solubilization and density gradient 
centrifugation were used to separate various subcellular fractions, followed by semi-quantitative 
determination of the relative abundance of specific receptor proteins in each fraction. D1 
receptors were predominantly localized to detergent-resistant membranes, and a portion of 
these receptors also floated on sucrose gradients. These properties are characteristic of 
proteins found in lipid rafts and caveolae. D2 receptors exhibited variable distribution between 
cytoplasmic, detergent-soluble and detergent-resistant membrane fractions, yet were not 
present in buoyant membranes. Most D5 receptor immunoreactivity was distributed into the 
cytoplasmic fraction, failing to sediment at forces up to 300,000g, while the remaining portion 
was localized to detergent-soluble membranes in cortex. D5 receptors were undetectable in 
detergent-resistant fractions or raft-like subdomains. Following daily cocaine administration for 
seven days, a significant portion of D1 receptors translocated from detergent-resistant 
membranes to detergent-soluble membranes and the cytoplasmic fraction. The distributions of 
D5 and D2 receptor subtypes were not significantly altered by cocaine treatment. These data 
imply that D5 receptors are predominantly cytoplasmic, D2 receptors are diffusely distributed 
across the cell, whereas D1 receptors are mostly localized to lipid rafts within the rat frontal 
cortex. Dopamine receptor subtype localization is susceptible to modulation by pharmacological 
manipulations that elevate synaptic dopamine. Given the molecular and functional interactions 
among dopamine receptor, the present pharmacological modulation of subcellular receptor 
distribution probably has functional implications that warrant further investigation.  
Keywords 
D1 dopamine receptor, D5 dopamine receptor, D2  dopamine receptor, cellular subdomains, 
receptor translocation, lipid rafts, cocaine 
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1. Introduction 
 
Dopamine receptor sensitivity and selectivity are modulated by the magnitude and 
duration of synaptic dopamine concentrations. Prolonged elevation of synaptic dopamine 
produces receptor desensitization (Cho et al., 2006; Memo et al., 1982), whereas persistent 
reduction of synaptic dopamine can lead to the development of postsynaptic dopamine receptor 
supersensitivity (Gerfen, 2003; Henry and White, 1991; Klawans et al., 1975; Mishra et al., 
1974). While numerous studies have documented dramatic changes in dopaminergic function 
as a consequence of experimental or disease-induced dopamine imbalance in the brain 
(Anderson and Pierce, 2005; Berthet et al., 2009; Guigoni et al., 2007; McGinty et al., 2008; 
Stanwood and Levitt, 2007), the mechanisms underlying such changes do not always involve 
changes in cell-surface receptor expression. To explain how function may change without a 
change in receptor number, some propositions have been advanced, including the mobilization 
of extrasynaptic receptors (Balfour et al., 2000; Korf and Loopuijt, 1988; Paspalas and 
Goldman-Rakic, 2004) as well as receptor internalization or receptor phosphorylation. More 
recently, receptor trafficking via signaling endosomes (Hanyaloglu and von Zastrow, 2008; 
Sadowski et al., 2009), receptor heterodimerization (Agnati et al., 2003; Lee et al., 2004; Lee et 
al., 2000; Pin et al., 2007), and plasma membrane receptor segregation across lipid rafts 
(Ostrom and Insel, 2004) have been explored as novel mechanisms that modulate dopamine or 
other G protein-coupled receptor signaling.  
The association of diverse receptors with lipid rafts – specialized nanoscale assemblies 
of cholesterol, sphingolipid and proteins – has raised the speculation that dopamine receptor 
subtypes may be differentially distributed within and outside these specialized structures, and 
that such distribution may have relevance to the pharmacology of this catecholamine. While it is 
clear from receptor trafficking experiments that synaptic dopamine concentration drives the 
subcellular location or endosomal transport of dopamine receptors (Dumartin et al., 1998; 
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Dumartin et al., 2000; He et al., 2009; Sun et al., 2003), it is still unknown if transmitter 
concentrations or exposure duration might influence the intra-membrane distribution of specific 
receptor subtypes, and how such influences may relate to physicochemical or functional 
receptor interactions or chronic alterations in receptor function.  
 In this study we used differential detergent solubilization and gradient centrifugation with 
subsequent immunodetection to examine dopamine receptor subtype localization in rat cortical 
tissues under basal conditions. We also induced alterations in synaptic dopamine activity via 
repeated administration of cocaine, and then re-examined the receptor subtype distribution 
profiles among the subcellular compartments. Since distinct signaling molecules can be 
enriched in specific subcellular compartments or plasma membrane subdomains, we tested the 
hypothesis that the intensity and duration of synaptic dopamine can drive dopamine receptor 
redistribution and thus direct the nature of receptor coupling to signal transduction cascades. 
 
 
2.0 Results 
 
2.1 Distribution of dopamine receptor subtypes among subcellular compartments 
 
Previous ligand-binding studies by our group and others suggested that dopamine 
receptor oligomerization and function can be modulated by exposure to reducing agents 
(Panchalingam and Undie, 2005; Sidhu, 1990; Sidhu et al., 1994). In the present study, we used 
rat cerebrocortical slices prepared through a process that was identical to conditions used in the 
prior functional studies examining various aspects of dopamine receptor-mediated biological 
activities (Panchalingam and Undie, 2005; Sidhu, 1990; Sidhu et al., 1994). Inclusion of a 
reducing agent (β-mercaptoethanol or dithiothreitol) in the sample loading buffer was essential 
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for visualization of monomeric and dimeric forms of the D1 subtype (Fig. 1A). The D1 receptors 
(~66kDa) were predominantly located in the detergent-resistant membrane (DRM) fraction, at 
more than 20 times the concentration found in the detergent-soluble membrane (DSM) fraction.  
FIGURE 1 HERE 
Under reducing conditions, the majority of D5 receptor immunoreactivity was observed 
as monomers in the cytoplasmic fraction with significantly less receptor protein in the DSM 
fraction; D5 receptors were undetectable in the cortical DRM fraction (Fig 1C). A monoclonal D1B 
(D5) receptor antibody also exhibited greatest immunoreactivity in the cytoplasmic fraction (Fig 
1G). The D2 receptor monomer (~55kDa) was observed predominantly in the DSM fraction, with 
less localized to the DRM fraction (Fig 1E). Under these conditions, where 20 µg of protein 
extract was loaded per lane, no D2 receptor immunoreactivity was detected in the cytoplasmic 
fraction. Nevertheless, the cytoplasmic D2 receptors appeared to be labile, with respect to 
cellular localization (Supp Fig 2). A correlation existed between the rapidity with which the tissue 
was removed and processed, and the ability to observe D2 receptors in the cytoplasmic fraction. 
Likewise, the duration of slice incubation was correlated with the ability to visualize D2 receptors 
in the cytoplasmic compartment. Finally, the data shown in Figure 1 were derived from 
membranes solubilized with 1% Triton X-100; however, the results were identical when 1% 
deoxycholate was used as the solubilizing agent (deoxycholate data not shown). 
Under non-reducing conditions the D1 receptor resisted solubilization as evidenced by 
the absence of immunoreactivity on Western blots. This observation was interpreted as support 
for the formation of a protein complex that was either too large or too insoluble to enter the gel 
matrix, resulting in the lack of detectable D1 receptor signal on Western blots (Fig 1B). This 
contrasted with the D5 and D2 receptors, where monomeric and oligomeric forms could readily 
be discerned under non-reducing conditions in the DSM and cytoplasmic fractions (Fig 1D, 1F). 
The strength of association of the non-migrating D1 receptor complexes was tested by exposing 
DRMs to urea or potassium iodide – reagents that can disrupt hydrophobic protein-protein 
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interactions (Brady et al., 2004). Neither denaturant was capable of dissociating D1 receptors 
from the insoluble complexes, indicating that the association was probably of a covalent nature 
(data not shown). 
To determine the specificity of the dopamine receptor antibodies used in this study, 
extracts from HEK293 cells expressing D2L receptors, and Sf9 cells expressing either D2L or D3 
receptors were screened by Western blot. The Santa Cruz D2 receptor antibody elicited 
immunoreactivity only in cells that were transfected with D2L, but not D3 receptor (Supp. Fig 1A, 
B). The specificity of the rabbit polyclonal D5 receptor antibody was demonstrated by comparing 
the immunoreactive profile of mouse hippocampal and liver tissue extracts. Immunoreactive 
proteins with molecular weights similar to that seen in rat cortex and striatum were observed in 
hippocampal, but not liver, extracts (Supp. Fig 1C); these observations correspond to previously 
published reports (Bergson et al., 1995; Luedtke et al., 1999). Blots were reprobed with β-actin 
to confirm equal loading of protein. Vascular tissue extracts (Cy, DSM, DRM) are shown to 
emphasize that β-actin comprises a smaller percentage of total protein in the DSM compared to 
cytoplasm and DRM, as noted in hipocampal and liver extracts (Supp Fig 1D). 
We next sought to characterize the cytoplasmic, DSM and DRM fractions by reprobing 
blots with antibodies for Rap1, Golf, Gi1, Gq/11 and PLCβ1 – dopamine receptor-related signaling 
components whose subcellular localization has previously been characterized (Canobbio et al., 
2008; Donati and Rasenick, 2005; Kelly et al., 2005). Rap1, Golf, Gq/11, Gi1 and PLCβ1 were all 
found in the DSM (Fig 2). Rap1 was the only protein tested that was not detected in DRM 
fractions; PLCβ1 was the only molecule detected in the cytoplasmic fraction. The non-receptor 
tyrosine kinases Src and Fyn have not been linked to direct activation by dopamine receptors, 
but have been found in both DSM and DRM (Patra, 2008; Yasuda et al., 2002). Src and Fyn 
were present in nearly equal amounts in both the DSM and DRM (Fig 2). Notably, Fyn, but not 
Src, was also found in the cytoplasmic fraction. The metabotropic glutamate receptor 5 
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(mGluR5) is another G protein-coupled receptor that was not expected to be present in the 
cytoplasmic fraction, and indeed was found to localize exclusively to DSM and DRM fractions 
(Fig 2). 
FIGURE 2 HERE 
 
2.2 Dopamine receptor localization among cellular subdomains  
 
In order to further characterize the DRM in which the D1 receptor was predominantly 
located, subcellular fractionation was carried out, adding a detergent step to separate DSM from 
DRM in each fraction. In these experiments, extracts were prepared from acutely isolated rat 
prefrontal cortex tissues. The data revealed that the D1 receptor was consistently localized to 
the DRM fraction, while residual amounts of the receptor could be detected in membrane 
subfractions sedimenting at each tested centrifugation step, including the 300,000g step (Fig 
3A). The D5 receptor was again found primarily in the cytoplasmic fraction comprised of the 
supernatant from centrifugation at 300,000g (Fig 3B). 
FIGURE 3 HERE 
In the case of the D2 receptor, the plasma membrane was the predominant fraction in which the 
receptor was found, with approximately equal distribution between DSM and DRM (Fig 3C). The 
remaining minor component of D2 receptors was distributed between the synaptosomal, 
microsomal and ribosomal membrane fractions. Interestingly, the ratio of D2 receptor in DSM 
and DRM was variable among these substructures. Synaptosomal DSM contained more of the 
D2 receptor than synaptosomal DRM, whereas for microsomal and ribosomal membranes the 
D2 receptor tended to locate more in the DRM fraction than the DSM. In this experiment and in 
the density gradient experiments, cross-reacting proteins of 60 – 70kDa were noted in the 
cytoplasmic fraction. These species have been described in the past as representing differing 
extents of glycosylation of the D2 receptor (Fishburn et al., 1995). Consistently, the predominant 
D2 receptor band was that which possessed a relative migration of approximately 55kDa. In 
these analyses, the controls included PSD95, which is detected only in the synaptosomal DRM 
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fraction (Fig 3D), and calnexin, which is enriched in the microsomal fraction, but can also be 
observed in the synaptosomal fraction (Archibald et al., 1999)(Fig 3E). 
2.3 Dopamine receptors display distinct buoyancies in sucrose gradients 
 
To further explore the idea that dopamine receptor subtypes partition differentially into 
membrane fractions within the cell, we carried out discontinuous sucrose density gradient 
fractionation using acutely isolated cortical membranes. This method has been used to isolate 
membrane subdomains that have distinct biochemical compositions or properties, such as lipid 
rafts and caveolae. We found a significant proportion of D1 receptors in buoyant membranes 
(Fig 4A), in fractions where flotillin (Fig 4D) and caveolin (Fig 4E) are observed. D1 receptors 
were distributed throughout the lower portion of the gradient, including the insoluble pellet (Fig 
4A). As predicted, PSD95 was restricted to the insoluble pellet (Fig 4F). Similar to what was 
observed in the crude fractionation experiments, the D5 receptors preferentially partitioned into 
the cytoplasmic phase while D2 receptors were found both in the cytoplasmic and membrane 
fractions. Neither the D2 nor the D5 receptor was present in any significant amount in buoyant 
membranes where flotillin, caveolin and D1 receptors were found (Fig 4B, 4C). 
FIGURE 4 HERE 
 
2.4 Cocaine induces cellular subdomain redistribution of D1 receptors in the frontal 
cortex 
 
Following a schedule of daily cocaine administrations over seven days, the distribution of 
D1 receptors was significantly shifted out of the DRM into the DSM and cytoplasmic fractions 
(Fig 5A). In contrast, cocaine administration did not alter the intercompartmental distribution of 
D5 or D2 receptors (Fig 5B, 5C). To control for equivalent sample loading, blots were reprobed 
with β3-tubulin (Fig 5D), α-synuclein (Fig 5E) and PSD-95 (Fig, 5F). While β3-tubulin and α-
 9 
synuclein were abundant in cytoplasmic and DSM membranes, and PSD-95 was observed 
solely in the DRM fraction, chronic cocaine administration did not alter the content or localization 
of any of these control proteins. 
FIGURE 5 HERE 
Striatal tissue from these same animals also was fractionated and assessed for changes 
in D1, D5, and D2 receptor distribution (Fig 6). Basal distribution of the receptors and subcellular 
markers in the saline-treated animals was similar to the distribution in naïve cortical tissue. 
Contrary to the observations in the frontal cortex, however, cocaine treatment failed to induce 
any significant redistribution of the dopamine receptor subtypes in the striatum. 
FIGURE 6 HERE 
 
 
3.0 Discussion 
 
We observed that dopamine receptor subtypes are differentially distributed among 
subcellular compartments, with the D1 subtype localized almost exclusively to detergent-
resistant membranes where raft and caveolar proteins are found, while the D5 subtype was 
largely localized to a cytoplasmic milieu that resisted sedimentation upon centrifugation up to 
300,000g. The D2 receptor subtype showed variable distribution between cytoplasmic, 
detergent-soluble and detergent-resistant membranes. Subacute cocaine treatment caused D1 
receptors to redistribute from detergent-resistant to detergent-soluble membranes, thus 
increasing the proportion of cellular D1 receptors that are juxtaposed with D2 receptors. A 
differential subcellular distribution of dopamine receptor subtypes in the brain, and the 
susceptibility of such distribution to pharmacological modulation, probably bears important 
implications for clarifying the mechanisms of functional alterations in dopamine signal 
transduction.  
 10 
 
3.1 Localization of dopamine receptors in cortex 
 
D1 receptors were preferentially localized to detergent-resistant brain membranes. Such 
membrane subdomains that are resistant to solubilization in cold Triton X-100 include 
postsynaptic densities, lipid rafts and caveolae. Thus, the present observations correlate with 
published reports of direct D1 receptor interactions with NMDA receptors, PSD-95 or caveolin-1 
– proteins that are known to reside in detergent-resistant subdomains or lipid rafts (Fiorentini et 
al., 2003; Kong et al., 2007; Lee et al., 2002; Pei et al., 2004; Zhang et al., 2007). Consistent 
with previous reports that D1 receptors resist solubilization in the absence of a reducing agent 
(Bergson et al., 1995; Sidhu, 1990), we found that disulfide bond disruption with β-
mercaptoethanol or DTT was essential to visualize D1 receptor monomers and dimers by 
Western analysis. This was intriguing as it implies that D1 receptors form covalently associated 
multimers (or the multimers may be covalently associated with some other membrane proteins). 
This inference is supported by the frequent observation of residual high molecular weight 
material on PAGE blots that reacts strongly with D1 receptor antibodies but fails to dislodge or 
migrate through the gel. The size of this residual complex was reduced in samples treated with 
reducing agent (data not shown). It was, however, unperturbed by treatment with strong 
denaturants such as urea or potassium iodide which effectively disrupt hydrophobic protein-
protein interactions.  
Inclusion of the cytoplasm for analysis was originally intended only as a control, as it was 
assumed that G protein-coupled receptors would ordinarily not reside to any appreciable extent 
in a cytoplasmic fraction. Nevertheless, D5 receptors were reproducibly and predominantly 
detected in the cytoplasm (200,000- 300,000g supernatant), an observation that was further 
confirmed with a monoclonal D5 receptor antibody. This characteristic distribution distinguishes 
the D5 from D1 receptors (Bergson et al., 1995). D5 receptors were typically detected as a 
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predominant band of approximately 50kD, with a second band at approximately 45kD. 
Previously published reports demonstrated that treatment of membrane extracts with 
deglycosylating enzymes caused the approximately 50kD D5 receptor band to migrate with the 
45kD marker (Bergson et al., 1995; Karpa et al., 1999), thus we postulate that the 45kD protein 
represents the deglycosylated form of the receptor. The nature of the approximately 66kD 
cytoplasmic protein detected with mouse anti-D5 receptor antibody has not been determined 
(Figure 1G). Previously published immunohistochemical analyses of D5 receptors in brain 
indicated that this receptor was present primarily in the somal cytoplasm in tissues where the 
receptor was expressed (Ariano et al., 1997; Bergson et al., 1995; Ciliax et al., 2000; Khan et 
al., 2000; Oda et al.). Similarly, in cultured cells D1 receptors were localized to the plasma 
membrane, whereas D5 receptor immunoreactivity was high in the somal cytoplasm and also 
present on the cell surface (He et al., 2009). The present determination that D5 receptors do not 
sediment at 300,000g suggests that these receptors are associated with a microvesicular 
membrane of high lipid content, rendering it difficult to sediment. Evidence for such 
microvesicles exists primarily in plants (Yao et al., 1991), although evidence for phospholipase 
C/phosphatidic acid-containing vesicles that resist sedimentation also exists in mammalian cells 
(Olsen et al., 1993). The recent finding that D5 receptors mediate stimulation of 
phosphoinositide signaling as well as CDP-diacylglycerol synthesis from phosphatidic acid 
(Sahu et al., 2009), together with the current finding of cytoplasmic localization of D5 receptors 
and PLCβ1, would be consistent with a preferential distribution of the receptors to 
sedimentation-resistant phospholipase C/phosphatidic acid-containing microvesicles. 
D5 receptor detection by Western blot in previous reports may have been missed or 
underestimated due to the receptor’s failure to sediment at forces reaching 300,000g. This 
single factor may have contributed to the conclusion that D5 protein levels are at the lower limit 
of detection by Western analysis (Rivera et al., 2002). Our enhanced method for separating 
membranes based on a combination of differential centrifugation and detergent solubility yielded 
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a broad estimate of receptor localization. Additional studies are required to more specifically 
address the source and nature of the microvesicular membranes with which D5 receptors prefer 
to associate. Finally, the observation that D5 receptor immunoreactivity was detected in 
detergent-resistant membranes of striatum (Figures 6 and Supplemental Figure 1C) does 
suggest that D5 receptor distribution may be brain-region dependent. 
D2 receptors were observed in all fractions and, compared to D1 or D5 subtypes, the D2 
distribution was rather labile as the compartmental proportions varied with conditions such as 
exposure to reducing agent or whether membranes had been freshly isolated from tissue or 
from slices pre-equilibrated ex vivo for 45 min (Lee et al., 2000). For example, D2 receptors 
were more frequently observed in the cytoplasm when extracts were rapidly obtained from 
acutely isolated cortical tissue, but were almost completely redistributed into the membrane 
fraction after slices were equilibrated by incubation in oxygenated HEPES-bicarbonate buffer at 
37 oC for up to 45 min (Supp Fig 2). Hence, D2 receptor localization is dynamic, shifting between 
compartments in response to conditions in the cellular environment. We hypothesize that the 
shifting of D2 receptors between compartments represents a biological phenomenon that 
reflects synaptic levels of neurotransmitter. Interestingly, it is well understood by 
electrophysiologists using the acute brain slice preparation that slices typically require a period 
of recovery, generally one hour post-processing. The data we present here may well provide a 
biological explanation for the need to re-equilibrate slices ex-vivo prior to initiation of 
electrophysiological analyses: the equilibration incubation allows for repositioning of the 
receptors in appropriate compartments for subsequent action. This is also consistent with 
existing evidence for alterations in D2 receptor function as a consequence of tissue handling 
(Vazquez et al., 2007). 
 
3.2 Membrane subdomains are enriched in specific receptor subtypes 
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We present here the first demonstration of D1 receptor subcellular localization into lipid 
raft-like entities in brain. D1, but not D2 or D5 receptors were observed in sucrose gradient 
fractions where lipid rafts and caveolae float. While the existence of caveolae in neurons is 
controversial, physical association of D1 receptors with caveolin has been demonstrated in HEK-
293 cells, COS-7 cells and whole brain extracts (Kong et al., 2007; Yu et al., 2004). 
D1 receptors were also found in the pellet at the bottom of the gradient, where 
membranes resistant to solubilization with 1% TX-100 are found, and where post-synaptic 
density proteins are located. D1 receptor co-localization with synaptosomal proteins was also 
noted in detergent-resistant synaptosomal membranes (Fig. 4). Distribution of D1 receptors 
within these substructures is consistent with studies concluding that D1 receptor interactions 
with NMDA receptors or PSD-95 influence D1 receptor function (Fiorentini et al., 2003; Pei et al., 
2004; Zhang et al., 2007). The observation that D1 receptors were found throughout the sucrose 
gradients may reflect an ability of the receptors to associate with diverse membranous 
structures in different cellular compartments (Vickery and von Zastrow, 1999), each perhaps 
characterized by distinct lipid compositions. The results of differential centrifugation support this, 
since D1 receptors were nearly equally distributed in DRM throughout the cell. 
 
3.3 Synaptic dopamine drives receptor localization 
 
Lipid rafts are biochemically distinct membrane subdomains theoretically providing 
flexibility and efficiency in signal transduction by segregating related signaling mediators. A 
hallmark of lipid rafts is the physicochemical segregation of cellular mediators that specify the 
coupling mechanisms for receptor-mediated signaling (Hancock, 2006; Harding and Hancock, 
2008; Ostrom and Insel, 2004). For example, translocation of G-proteins and other signaling 
molecules into and out of rafts aids in directing cellular responses to specific agonist stimulation 
(Allen et al., 2007; Head et al., 2006; Patel et al., 2008). Since repeated exposure to abused 
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drugs results in molecular adaptations in neuronal signaling, we questioned whether the 
associated changes in synaptic dopamine concentrations could induce dopamine receptor 
subtypes to translocate between subcellular domains in a manner that might predicate changes 
in signaling function. Seeing that cocaine treatment induced a significant and selective 
redistribution of D1 subtype receptors, we may conclude that synaptic dopamine activity can 
modulate receptor distribution within the plasma membrane and possibly in exchange with other 
cellular compartments such as endosomes. A recent in vitro experiment with D1 and D5 
receptor-expressing cells observed a similar behavior of these two receptors in response to 
agonist: D1 receptors translocated from the plasma membrane to intracellular sites while D5 
receptors did not undergo a significant shift when exposed to agonist (He et al., 2009). It is 
generally known that excessive or persistent stimulation can induce internalization of G protein-
coupled receptors, leading to lysosomal degradation of the receptors or subsequent recycling of 
the receptors back to the plasma membrane. In the present study, it is not clear if the 
redistribution of D1 receptors was to reposition them for alternative signal transduction coupling, 
to gain access to compartments where the receptors would be degraded, or if the receptors 
were being sequestered to be preserved for subsequent recycling and reuse. The observation 
that total D1 receptor immunoreactivity across all compartments appeared unchanged between 
saline and cocaine treatment groups suggests that the receptor redistribution is probably aimed 
at modulating the type or strength of coupled signaling cascades.  
In summary, we have uncovered several features related to differences in the subcellular 
distribution of D1, D2 and D5 dopamine receptors. These differences are predicted to have 
significant impact on receptor signaling as well as the potential susceptibility of various receptor 
subtypes to functional modulation by alterations in synaptic neurotransmission. Additionally, 
localization of dopamine receptor subtypes within physicochemically distinguishable cellular 
subdomains in brain tissues could set the stage for diverse cellular-level receptor-receptor 
interactions (or lack thereof), yielding new insights into the regulation and function of these 
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receptors. Dopamine receptors are critical components of neuronal circuits involved in memory, 
motor coordination and reward. Addiction, Parkinson disease and schizophrenia are among the 
diseases exhibiting altered dopaminergic signaling (Anderson and Pierce, 2005; Berke and 
Hyman, 2000; Graybiel et al., 1994). The present finding of differential but dynamic localization 
of dopamine receptor subtypes suggests a potentially novel mechanism for the regulation of 
dopamine neurotransmission under physiologic conditions or as part of the pathophysiology of 
various dopamine-associated disorders. 
 
 
4.0 Experimental methods 
 
4.1 Animals 
Male Sprague-Dawley rats weighing 250-275g were purchased from Zivic Laboratories, 
Pittsburg, PA. The animals were caged in groups of three and housed in climate-controlled 
facilities with a 12-h light/dark cycle and free access to food and water. Protocols for the care 
and use of the experimental animals were approved by the Institutional Animal Care and Use 
Committee and conformed to the principles set forth in the National Institutes of Health Guide 
for the Care and Use of Laboratory Animals. 
 
4.2 Materials 
Cocaine hydrochloride was obtained from the National Institute on Drug Abuse, Bethesda, MD. 
All other reagents, including a protein inhibitor cocktail comprising 4-(2-aminoethyl) 
benzenesulfonyl fluoride, E-64, bestatin, leupeptin and aprotinin, were obtained from Sigma-
Aldrich (St. Louis, MO). 
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4.3 Cocaine administration 
Rats were administered intraperitoneal (i.p.) injections of either 0.9% sterile saline as control or 
20 mg/kg cocaine dissolved in 0.9% sterile saline. Injections were administered to the animals in 
their home cage, and repeated once each day for seven days. Animals were euthanized 24 h 
after the last injection. Brains were quickly removed and frontal cortical tissues were dissected 
out as previously described (Undie and Friedman, 1990). 
 
4.4 Preparation of tissue slices 
Dissected cortices were chopped into 350 x 350 µm slices using a McIlwain tissue chopper. 
Slices were washed three times in 20 volumes of HEPES-bicarbonate buffer containing, in mM: 
NaCl 122, KCl 4.9, KH2PO4 1.2, MgCl2 1.2, NaHCO3 36, HEPES 30 and glucose 10. The 
suspension was aerated with 95% O2/5% CO2 and incubated for 15 min at 37 °C with 
continuous reciprocal shaking. The buffer was then exchanged by washing three times with 
HEPES bicarbonate buffer that contained 1.2 mM CaCl and slices were equilibrated in a fresh 
aliquot of the buffer for an additional 45 min. Following a brief low-speed centrifugation, excess 
buffer was removed to obtain a slurry of packed slices (Undie and Friedman, 1990). 
 
4.5 Isolation of cytoplasmic and membrane fractions 
Tissue from one rat was collected into 1 ml of homogenization buffer comprised of 10 mM 
HEPES, pH 7.4, 2 mM EDTA, 320 mM sucrose and 2% (v/v) protease inhibitor cocktail. The 
material was transferred to a glass/Teflon homogenizer and homogenized gently on ice with 18-
20 strokes. The homogenate was centrifuged at 1000g for 10 min to pellet nuclei and cellular 
debris (P1 fraction). The supernatant (S1) was reserved and the P1 pellet was washed with 1 ml 
of homogenization buffer and centrifuged again at 1000g for 5 min. The pooled supernatants 
were centrifuged for 5 min at 1000g to remove residual debris. This post-nuclear fraction was 
then centrifuged for 45 min at 200,000g. The supernatant (S2) corresponding to a crude 
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cytoplasmic fraction was saved; the crude membrane pellet (P2) was washed in 1 ml of 
membrane buffer (25 mM HEPES, pH 7.4, 2 mM EDTA and protease inhibitors) and both the 
cytoplasmic and membrane fractions were centrifuged again at 200,000g for 30 min. The 
cytoplasmic fraction was saved for further analysis. The P2 pellet was resuspended in 
membrane buffer and homogenized with 8-10 strokes on ice. To solubilize membranes, Triton 
X-100 (or sodium deoxycholate as indicated) was added to a final concentration of 1% and the 
extracts were incubated overnight at 4°C. Membranes were subsequently centrifuged at 
200,000g for 45 min. The supernatant (S3) from this step was retained as the DSM fraction. The 
pellet (P3) comprised the DRM fraction. The DRM pellet was washed with membrane buffer, 
recovered by centrifugation at 200,000g for 30 min, and then resuspended in membrane buffer 
containing 1% Triton X-100. The DSM fraction was further cleared by centrifugation at 200,000 
g for 30 min, retaining the supernatant for subsequent analyses. 
In some experiments, differential centrifugation was used to obtain a mitochondrial 
fraction (12,500g, 15 min), plasma membrane (23,000g, 30 min), microsomal membrane 
(100,000g, 1.5h), and ribosomal membrane fractions (300,000g, 2h). Synaptosomes were 
enriched from the mitochondrial fraction by separation over a discontinuous sucrose gradient. 
The gradient was formed by layering 2.4ml of 1.2M sucrose in the bottom of a 13 ml tube, 
followed by a layer of 7.2ml of 0.8M sucrose. The mitochondrial/synaptosomal pellet was 
resuspended in 2.4ml of 0.3M sucrose and layered on top of the 0.8M sucrose layer. Gradients 
were centrifuged at 54,000g for 2h. The synaptosomal layer was collected from the interface 
between 1.2 and 0.8M sucrose and centrifuged at 100,000g for 1 h in order to pellet 
synaptosomal membranes. Triton X-100-soluble and resistant synaptosomal fractions were 
isolated as described above by pretreating the sample with 1% Triton X-100 followed by 
centrifugation at 200,000g for 30 min. 
 
4.6 Sucrose gradient ultra-centrifugation and TCA precipitation 
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All manipulations were carried out on ice or at 4°C. Cortical tissues were isolated from three 
animals and the tissues pooled for processing in order to recover sufficient amounts of DRM 
material for analysis. The cytoplasmic and P2 membrane fractions were isolated as described 
above. The P2 membrane pellet was resuspended in 0.9 ml of MES buffered saline (MBS; 
comprised of 40 mM MES, pH 6.5, 150 mM NaCl, 2% protease inhibitors) and homogenized 8-
10 strokes on ice. Triton X-100 was added to a final concentration of 1%. Membranes were 
mixed 1:1 with 85% sucrose in MBS, placed in the bottom of a 13 ml polyallomer tube and 
carefully overlaid with 6 ml of cold 35% sucrose/MBS followed by 4 ml of 5% sucrose/MBS 
using a 22 G syringe. The gradients were centrifuged for 19 h at 182,000g and 4°C in an 
SW40Ti rotor (Beckman-Coulter). Fractions (1ml) were gently collected from the top of the 
gradient (from Fraction #1 at the top to Fraction #12 at the bottom). Each pellet was 
resuspended in 0.5 ml MBS and mixed with an equal volume of 85% sucrose. 
Cold 100% trichloroacetic acid (TCA) was added to each fraction such that the final 
concentration was 20%. Samples were kept on ice for 15 min and then centrifuged at 22,500g 
and 4°C for 15 min. Samples were immediately placed on ice, and the clear upper layer was 
removed leaving the cloudy lower layer. To each sample, 700µl of acetone was added and 
tubes were centrifuged for 10 min at 22,500g. Acetone was removed and samples were dried 
overnight in a fume hood. To resuspend, 250µl of 20 mM Tris, pH 8.0 was added to each 
sample, followed by trituration with 8 strokes of a glass/Teflon homogenizer. Triton X-100 was 
added to a final concentration of 1%, and fractions were subsequently analyzed by Western 
blotting. 
 
4.7 Dopamine receptor antibody specificity 
Cell lysates from Sf9 cells were a generous gift from R.R. Luedtke. Sf9 cells were either 
untransfected, transfected with D2L receptor, or transfected with D3 receptor. Prior to western 
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blotting, these extracts were tested for D2L receptor binding activity by the Luedtke laboratory. 
Only Sf9 cells transfected with D2L receptor demonstrated activity in a D2 receptor radioligand 
binding assay. Protein content was quantified and 1µg of each lysate was loaded per lane. 
HEK293 cells were stably transfected with a triple HA-tagged D2L dopamine receptor, and 
selective pressure was maintained with 100µg/ml G418. Cell growth media was DMEM with 
10% fetal bovine serum, penicillin/streptomycin and glutamine. HEK293 cells (no D2 receptor) 
and HEK293-D2L receptor-expressing cells were collected and lysed with 10mM Tris, Ph 7.4, 
150mM NaCl and 1% Triton X-100, and the resultant membranes used for downstream 
analyses.  
 
 
4.7 Protein quantitation and Western blot analysis 
Sample aliquots were taken for quantitation of protein using the Pierce BCA protein assay kit 
(Rockford, IL). Equivalent amounts (micrograms) of each sample were separated on Invitrogen  
(Carlsbad, CA) NuPage 4-12% Bis-Tris gels with MES running buffer. Gels were transferred to 
nitrocellulose membranes at 30V for 16h at 4°C. Membranes were stained post-transfer with 2% 
Ponceau S to identify and rerun blots with uneven lane loading. Membranes were blocked with 
10% milk/Tris-buffered saline, 1% Tween 20 (TBST) and probed with primary antibody in 5% 
milk/TBST. Horseradish peroxidase (HRP)-conjugated secondary antibodies (goat anti-mouse, 
1/5000; KPL, Gaithersburg, MD); donkey anti-rabbit, 1/10,000 Chemicon) were used in 
conjunction with Pierce West Pico chemiluminescent reagents to visualize immunoreactivity. For 
visualization of dopamine receptors, Pierce Femto reagent was added to Pico at a 20:1 
(Pico:Femto) ratio. Rabbit polyclonal antibody against D1 dopamine receptor (D1DR) or D5 
dopamine receptor (D5DR) was used at a 1/1000 dilution for Western blot analysis; mouse anti- 
D2 dopamine receptor (D2DR) was used at a 1/500 dilution. Primary antibodies used in this 
study included the following. D1 receptor (rabbit polyclonal, a.a. hum 338-446 (H-109), sc-
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14001), D2 receptor (mouse monoclonal, a.a. hum 1-50, clone (B-10), sc-5303), D5 receptor 
(rabbit polyclonal, a.a. hum 371-477, (H-107), sc-25650), a-synuclein (rabbit polyclonal, (C-20) 
7011-R), Gαolf (rabbit polyclonal sc-385) Gαi-1 (rabbit polyclonal sc-28586), Gq/11 (rabbit 
polyclonal sc-392) and PLCβ1 (rabbit polyclonal sc-205) were purchased from Santa Cruz 
Biotechnology (Santa Cruz, CA). The D1b antibody (mouse monoclonal, specific for the D1b/D5 
receptor) was a generous gift from R. Luedtke (University of North Texas Health Science 
Center, Fort Worth, TX). β3-tubulin (mouse clone 3D10, T-8660), β-actin (A-5316) and caveolin-
1 (rabbit c-3237) were obtained from Sigma-Aldrich (St. Louis, MO). PSD95 (mouse clone 6G6-
1c9, MA1-045) was purchased from Affinity Bioreagents (Golden, CO) and Rap-1 (rabbit, KAP-
GP120) was from StressGen (Ann Arbor, MI). Rabbit anti-mGluR5 was purchased from Upstate 
Biotechnology Inc. (Waltham, MA). Src (mouse clone 327) was a gift from Jo Bolen (Millenium 
Pharmaceuticals), Fyn (rabbit BL90) was a gift from Mike Tomlinson (University of Birmingham, 
UK), and calnexin (rabbit, Sigma) was a gift from Peter Swaan (University of Maryland). The 
Santa Cruz anti-D5 receptor antibody was used in all experiments except for that shown in 
Figure 1G. Selectivity of the D5 and D2 receptor antibodies are demonstrated in Supplemental 
Figure 1. Data reported in the graphs have not been normalized to loading controls, because 
the distribution of loading controls was not equivalent across the three compartments examined 
(cytoplasmic, DSM, DRM). This critical issue has been addressed recently (Aldridge et al., 
2008). Chemiluminescence images were collected onto Kodak Blue XB-1 film, and 
subsequently scanned and quantitated by densitometry using ImageQuant (v. 1.2, Molecular 
Dynamics). 
 
4.8 Data analysis 
 21 
Quantitative data are expressed as mean+/- SEM. Statistical analysis was conducted using 
one-way analysis of variance (ANOVA), followed by a post-hoc Bonferroni-Dunnett test 
(Statview). 
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7.0 Figure legends 
 
Fig. 1.     D1, D5 and D2 dopamine receptors are differentially distributed among 
subcellular fractions in rat cortex. Samples of cytoplasm (Cy), detergent-soluble membranes 
(Ds), and detergent-resistant membranes (Dr) were electrophoresed under either reducing (A, 
C, E, G) or non-reducing (B, D, F) conditions. A, Under reducing conditions D1 receptors are 
visualized primarily in the Dr membrane fraction. B, D1 receptors are undetectable in the blots 
under non-reducing conditions. C, D, D5 receptor monomers and dimers are most abundant in 
the cytoplasmic fraction, but also present in Ds membranes (rabbit polyclonal antibody). E, D2 
receptor immunoreactivity is present mainly in Ds and Dr fractions. F, Under non-reducing 
conditions D2 receptors migrate as high molecular weight, multimeric forms, most predominantly 
in the cytoplasm, but monomers and multimers are also present in Ds and Dr fractions. G, 
distribution of D5 receptor immunoreactivity is similar when detected with a mouse monoclonal 
antibody. Each extract was loaded with 20 µg protein except the Dr analysis for D1 receptor 
detection (#) where only 4 µg protein was loaded. Blots were reprobed with β-actin to confirm 
equal loading of protein. The data in this figure are representative of 4 separate experiments. 
 
Fig. 2.     Distribution of signaling molecules into cytoplasmic, detergent soluble and detergent 
resistant membrane fractions in cortical tissue. A, Components of dopamine-sensitive signaling 
pathways are primarily localized to Ds and Dr membranes; only PLCβ1 was detected in the 
cytoplasmic fraction. B, The tyrosine kinases Src and Fyn were associated with Ds and Dr 
membranes; Fyn, but not Src could be detected in the cytoplasm. C, Another G protein coupled 
receptor, metabotropic glutamate receptor 5 (mGluR5) distributed into both the Ds and Dr 
membrane fractions. Twenty micrograms of protein was loaded per lane, except for Dr in panel 
B, where only 4µg total protein needed to be loaded. 
 
Fig. 3.     Differential centrifugation of cortical membrane fractions reveals dopamine receptor 
distribution across distinct cellular subdomains. Fractions are designated as: S, synaptosomal 
fraction (12,500g pellet); P, plasma membrane fraction (23,000g pellet); µ, microsomal 
membrane fraction (100,000g sediment); R, ribosomal fraction (300,000g sediment); and Cy, 
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cytoplasmic fraction (300,000g supernatant). A, D1 receptors are restricted to Dr membranes of 
various buoyancies throughout the cell. B, D5 receptors are visualized primarily in the 300,000g 
cytoplasmic fraction. C, D2 receptors are observed in every fraction examined, with varying 
percentages in the Ds versus Dr fractions. Blots were reprobed for PSD-95 and calnexin to 
validate the efficiency of fractionation. 
 
Fig. 4.     Cortical D1 receptors, but not D5 or D2 receptors float on sucrose density gradients. 
Western blot analysis was conducted using discontinuous sucrose gradient fractions, and 
shown in the figure are representative gradient profiles. A, D1 receptor-containing membranes 
localize to fractions where the lipid raft protein flotillin (D) and the caveolar protein caveolin (E) 
are found. D1 receptors are also present in diverse detergent-soluble membranes and in the 
detergent-resistant pellet, where PSD-95 (F) is located. B, D5 receptors are only detectable in 
the 200,000g supernatant (cytoplasmic) fraction. C, D2 receptors are distributed between the 
cytoplasmic, detergent-resistant pellet and detergent-soluble fractions, but are clearly absent 
from the raft fraction. All panels were derived from the same gradient. Graph inserts on the right 
represent densitometric quantification of the immunoreactivity in each fraction (compiled from 
two independent experiments) as a percentage of summed immunoreactivity in all fractions, for 
each individual protein. 
 
Fig. 5.     Cocaine treatment causes subcellular redistribution of cortical D1 receptors, but not D2 
or D5 receptors. Twenty micrograms of each extract was loaded per lane, except for detection of 
D1 receptors in Dr (#, 4µg). A, In saline-treated rats, D1 receptors are localized to the Dr fraction, 
while cocaine treatment shifts D1 receptors from Dr into Ds and Cy. B, Cocaine administration 
does not alter D5 receptor location. C, Following repeated saline or cocaine injection, D2 
receptors were preferentially found in Dr membranes. D, E, F, Blots were reprobed with β3-
tubulin, α-synuclein or PSD-95 to demonstrate equal loading, and the lack of a generalized 
cocaine effect on cellular distribution of these proteins. For each condition, immunoreactivity 
was quantified in each fraction for each protein and expressed as a percentage of summed 
immunoreactivity in all fractions of the protein for that condition. Data are expressed as mean ± 
SEM (n = 5). *p < 0.05.  
 
Fig. 6.     Repeated cocaine administration does not elicit changes in dopamine receptor 
localization in the dorsal striatum. Striatal tissue from the same animals analyzed in Figure 4 
was fractionated and assessed for changes in dopamine D1, D5 and D2 receptor content 
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following repeated dosing with cocaine. Twenty micrograms of each extract was loaded per 
lane, except for detection of D1 receptors in Dr (#, 4µg). A, striatal D1 receptors are enriched in 
the Dr fraction. B, striatal D5 receptors are detected primarily in the cytoplasmic fraction and to 
some extent in the Dr membranes. C, striatal D2 receptors are found mainly in the Dr membrane 
fraction. Blots were reprobed with β3-tubulin, α-synuclein or PSD-95 to demonstrate equal 
loading, and check for any generalized effect of cocaine on subdomain distribution of cellular 
proteins. For each condition, immunoreactivity was quantified in each fraction for each protein 
and expressed as a percentage of summed immunoreactivity in all fractions of the protein for 
that condition. Data are expressed as mean ± SEM (n = 5) *p< 0.05. 
 
Supplemental Figure 1.     Selectivity of dopamine receptor antibodies. A, D2 receptor 
immunoreactivity was detected only in lysates from HEK 293 cells that expressed D2L 
receptors; 20µg of lysate was loaded per lane. B, D2 receptor immunoreactivity was observed in 
lysates from Sf9 cells that overexpressed D2L, but not D3 receptors; 1µg of lysate was loaded 
per lane. C, D5 receptor immunoreactivity was observed in hippocampal, but not liver extracts. 
Twenty micrograms of cytoplasmic, DSM or DRM was loaded per lane. β-actin was used to 
demonstrate presence of protein in the liver extracts. 
 
Supplemental Figure 2.     Detection of D2 receptors in cortical cytoplasmic fractions is 
dependent on preparation. A, D2 receptors were observed in cytoplasm of acutely isolated 
tissue extracts, whereas further processing (acute slices for ex-vivo stimulation) rendered the 
D2 receptors undetectable in cytoplasmic extracts for up to 60 minutes post-slice preparation. B, 
C, D2 receptor immunoreactivity in DSM and DRM was not altered by preparation. All panels, 
20µg total extract was loaded per lane. 
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